The Global Molecular Diagnostics Market is estimated to witness a CAGR of 8.5% during the forecast period 2017-2023. The Molecular Diagnostics market is analyzed based on four segments, namely application, technology, end-users, and regions.

The market for molecular diagnostics is driven by the increasing prevalence of infectious diseases, growing adoption of point-of-care testing, increasing demand for biomarker-based test, and high growth of the market in emerging countries. The growing significance of companion diagnostics, increased number of M&A, and the increased adoption of DNA probe-based diagnostics are providing market growth opportunities. However, stringent regulatory approval and lack of skilled labors are hampering the market growth.

The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the molecular diagnostics market followed by Europe. Various countries in the Americas are taking initiatives for the elimination of viral hepatitis and the major challenge remains in the diagnosis of this disease. This is providing an opportunity for the manufacturers to enhance their market presence. Asia Pacific is expected to have the fastest growth rate due to the high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by rest of the world, in terms of the growth rate during the forecast period.

Currently, the PCR market is dominating the global molecular diagnostics market, but a lot of new players are focusing on developing microarray and next-generation sequencing technologies to gain future business opportunities. Significant investments in R&D in this market is seen to develop novel technologies. As a support, many companies are receiving funds to develop advanced technology products from diagnostics associations and other venture capitalists.

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outlook

5 Market Characteristics

6 Market Segmentation by Technology: Market Size and Analysis

7 Market Segmentation by Application: Market Size and Analysis

8 End-user: Market Size and Analysis

9 Regions: Market Size and Analysis

10 Competitive Landscape

11 Vendor Profiles

12 Companies to Watch For

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation.
  • F.Hoffmann-La Roche Ltd
  • Hologic Inc.
  • QIAGEN NV
  • Siemens Healthineers Inc.
  • ThermoFisher Scientific.

For more information about this report visit https://www.researchandmarkets.com/research/6tctkr/worldwide

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Powered by WPeMatico

SHARE
Previous articleNuWave Communications Announces SIP TRUNK Vendor Agreement with Ingram Micro
Next articleResearch Report Covers the Airport Passenger Screening Systems Market Share and Growth by 2024
Harry
Arul Is a researcher and law student at Anna University (Chennai). He has worked as the Director of the Graduate Lawyering Program.